Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | SYK | P43405 | 7/20 | 0.39 |
| ▸ | RHOA | P61586 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | DDX3X | O00571 | 1/20 | 0.36 |
| ▸ | RECQL | P46063 | 1/20 | 0.35 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.35 |
| ▸ | AURKA | O14965 | 1/20 | 0.35 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | CDK2 | P24941 | 1/20 | 0.35 |
| ▸ | ZAP70 | P43403 | 1/20 | 0.35 |
| ▸ | NQO2 | P16083 | 1/20 | 0.34 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.34 |
| ▸ | KCNH3 | Q9ULD8 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12785977 | 0.81 | DDX3X (0.43) | LMNASYKKMT2AMEN1MAPT | |
| SCHEMBL31579242 | 0.80 | BACE1 (0.57) | BACE1LMNAKMT2AMEN1MAPT | |
| SCHEMBL23868902 | 0.80 | ALDH5A1 (0.44) | RHOAKMT2AMEN1MAPTKDM4E | |
| SCHEMBL7564159 | 0.77 | SYK (0.64) | SYKRHOAKMT2AMEN1HDAC6 | |
| SCHEMBL22356493 | 0.75 | SYK (0.62) | SYKRHOAKMT2AMEN1HDAC6 | |
| SCHEMBL5959433 | 0.74 | AURKA (0.59) | LMNASYKKMT2AMEN1MAPT | |
| SCHEMBL7961759 | 0.73 | TTR (0.44) | KMT2AMEN1MAPTMAPK1GAA | |
| SCHEMBL7960772 | 0.73 | CYP3A4 (0.44) | SYKRHOAKMT2AMEN1MAPT | |
| SCHEMBL29819598 | 0.72 | CYP3A4 (0.74) | SYKRHOAKMT2AMEN1MAPT | |
| SCHEMBL12513290 | 0.72 | CYP3A4 (0.74) | SYKRHOAKMT2AMEN1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210301180-A1 | COMPOSITION, THERMALLY CONDUCTIVE SHEET, AND DEVICE WITH THERMALLY CONDUCTIVE LAYER | FUJIFILM CORPORATION (JP) | 2021-09-30 | — | — | US | disclosed |
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | CRYSOPTIX KK | 2011-03-17 | — | — | US | disclosed |
| EP-2260036-A2 | POLYCYCLIC ORGANIC COMPOUNDS, RETARDATION LAYER AND COMPENSATION PANEL ON THEIR BASE | CRYSOPTIX K.K. (JP) | 2010-12-15 | — | — | EP | disclosed |
| WO-2009109782-A2 | POLYCYCLIC ORGANIC COMPOUNDS, RETARDATION LAYER AND COMPENSATION PANEL ON THEIR BASE | CRYSOPTIX K.K. (JP) | 2009-09-11 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110064892-A1 | Polycyclic Organic Compounds, Retardation Layer and Compensation Panel on Their Base | MCM3, CCNA2, CCNB2 | BACE1 2184/4885LMNA 115/4885SYK 3171/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.